
Amphastar Pharmaceuticals announced that CFO Bill Peters and EVP Tony Marrs will present at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026. The presentation will be webcast and available for 30 days on Amphastar's website. Amphastar focuses on developing and commercializing generic and proprietary injectable, inhalation, and intranasal products, along with active pharmaceutical ingredients. This event provides insight into the company's strategy and future outlook in the healthcare sector.